Somatostatin receptor scintigraphy in non-medullary thyroid cancer.
Digestion
; 57 Suppl 1: 36-7, 1996.
Article
de En
| MEDLINE
| ID: mdl-8813465
ABSTRACT
8 patients with papillary cancer (4 with metastases, 4 in remission), 7 follicular cancer patients (6 with metastases), 2 patients with anaplastic thyroid cancer and 4 other non-medullary thyroid cancer patients all received an intravenous bolus injection of 220 MBq [111In-DTPA-D-Phe1]octreotide. Planar anterior and posterior gamma camera images of head-neck, chest and abdomen were obtained 24 and 48 h after injection. All primary cancers showed [111In-DTPA-D-Phe1] octreotide uptake; none occurred in patients in remission. The results were compared with conventional radio-iodine scintigraphy in patients with metastasised, differentiated thyroid cancer.
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs de la thyroïde
/
Carcinome papillaire
/
Récepteur somatostatine
/
Carcinome papillaire folliculaire
Type d'étude:
Diagnostic_studies
Limites:
Humans
Langue:
En
Journal:
Digestion
Année:
1996
Type de document:
Article
Pays d'affiliation:
Pays-Bas